MGNX

1.9601.01%
EB

Eric Blasius Risser

CEO, President & Director

Mr. Eric Blasius Risser is President, Chief Executive Officer and Director at MacroGenics, Inc. since August 13, 2025. He served as Chief Operating Officer at MacroGenics, Inc. since February 22, 2022 until August 13, 2025. He had been Chief Business Officer and Senior Vice President of Business Development and Portfolio Management at MacroGenics, Inc. since September 2016 until February 22, 2022. Mr. Risser served as Vice President of Business Development at MacroGenics, Inc. since March 2009. He has a wealth of strategic and transactional experience. Prior to joining MacroGenics, he served as Senior Director, Business Development at Johnson & Johnson Pharmaceuticals from 2003 to 2009. While at Johnson & Johnson, he was responsible for leading global transactions in the pharmaceuticals area, including company acquisitions, product licenses and research collaborations. His areas of expertise include originating collaboration opportunities, managing multi-disciplinary project teams, structuring and negotiating transactions and formulating integration and alliance management plans. Before Johnson & Johnson, he started and built a successful consulting practice that provided counsel to emerging life science companies in the United States and Europe. He has also worked as a venture capitalist with BankAmerica Ventures as an investment banker with Lehman Brothers, where he began his career in their New York and London offices. Mr. Risser holds an M.B.A. from Stanford University and a B.A. from Yale University.

Positions